.After antibody-drug conjugate (ADC) specialist Seagen was marketed to Pfizer in 2013 for a tremendo...
.On the heels of a period 3 gain that fell short to wow clients, Ironwood Pharmaceuticals is back al...
.Do not quit Monte Rosa Rehabs right now. The Boston-based biotech is actually enjoying after signin...
.Accept to recently's Chutes & Ladders, our roundup of substantial leadership hirings, firings an...
.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the positi...
.AbbVie has actually returned to the resource of its antipsychotic giant Vraylar looking for one mor...
.GenSight Biologics is actually full weeks off of running out of funds. Once more. The biotech simpl...
.Monopar Therapeutics is recuperating a drug from the dump of AstraZeneca's uncommon disease pipelin...
.Along with brand new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of pro...
.After creating a genetics treatment partnership along with Dyno Therapeutics in 2020, Roche is actu...
.Lundbeck is actually lowering the book worth of its $250 million Abide Therapies buyout in reaction...
.The integration of real-world data (RWD) right into protocol feasibility and internet site variety ...
.At this year's Intense Biotech Top in Boston ma, our team caught up with leaders in the biotech sec...
.Merck & Co. is taking down $30 million in advance to purchase Yale spinout Modifi Biosciences, a...
.Alpha-9 Oncology has increased a $175 million collection C round to stake its clinical-stage radiop...
.Eye medicine producer Ocuphire Pharma is actually getting genetics therapy programmer Opus Genetic ...
.Roche's persistent coughing plan has actually faltered to a stop. The drugmaker, which axed the sys...
.Gilead Sciences as well as Merck & Co. have helped their once-weekly HIV combo treatment past ye...
.Lykos Therapies might have lost three-quarters of its workers back the FDA's rejection of its own M...
.Septerna may be yet to divulge "any sort of purposeful clinical records," but the biotech clearly b...